Cargando…
Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas
OBJECTIVES: Two pilot studies of AR‐42, a pan‐histone deacetylase inhibitor, in human neurofibromatosis type 2 (NF2), vestibular schwannomas (VS), and meningiomas are presented. Primary endpoints included safety, and intra‐tumoral pharmacokinetics (PK) and pharmacodynamics (PD). METHODS: Pilot 1 is...
Autores principales: | Welling, D. Bradley, Collier, Katharine A., Burns, Sarah S., Oblinger, Janet L., Shu, Edina, Miles‐Markley, Beth A., Hofmeister, Craig C., Makary, Mina S., Slone, H. Wayne, Blakeley, Jaishri O., Mansouri, S. Alireza, Neff, Brian A., Jackler, Robert K., Mortazavi, Amir, Chang, Long‐Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513424/ https://www.ncbi.nlm.nih.gov/pubmed/34667843 http://dx.doi.org/10.1002/lio2.643 |
Ejemplares similares
-
Testimony by otolaryngologists in defense of tobacco companies 2009–2014
por: Jackler, Robert K.
Publicado: (2015) -
Extracranial head and neck schwannomas: a study of the nerve of origin
por: Liu, Hin-Lun, et al.
Publicado: (2011) -
Evaluation of MR imaging findings differentiating cavernous haemangiomas from schwannomas in the orbit
por: Xian, Junfang, et al.
Publicado: (2010) -
Diffusion-weighted imaging in extracranial head and neck schwannomas: A distinctive appearance
por: Das, Abanti, et al.
Publicado: (2016) -
Schwannoma of the ansa cervicalis
por: Okonkwo, O, et al.
Publicado: (2011)